Lilly launches vials of weight-loss drug Zepbound for as low as $399 a month
) said on Tuesday it has begun selling vials of the lowest starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month's supply through its direct-to-consumer website to help increase its availability in the marketplace.
That is a $250 discount, or 40%, for the lowest dose compared to the $650 per month Lilly now charges patients for the pen version of Zepbound on its website, an increase from the $550 launch price set early this year. Lilly's drugs are now listed as available by the U.S. Food and Drug Administration, though they are not yet off the FDA's official shortage list where they have been most of the year.
Shares of Hims and Hers Health, a telehealth company that offers compounded versions of Novo's weight-loss drug for as little as $199 a month, were down 7% at $14.91.Patrik Jonsson, Lilly's president of cardiometabolic health, said in an interview that the vials launch will significantly increase supplies of Zepbound in the U.S.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Lilly Launches Single-dose Vials Of Zepbound for Weight Loss to Expand US SupplyEli Lilly said it has begun selling single-dose vials of its popular weight-loss drug Zepbound in the U.S., aimed at patients who cannot get the cost of the medicine...
Read more »
Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vialsThe cheaper drug will compete with compounded versions of the same medication sold by digital health companies.
Read more »
Eli Lilly releases discounted single-dose vials of Zepbound weight loss drugRooted in fact-based, transparent reporting, Newsy is an award-winning opinion-free network owned by the E.W. Scripps Company that is relentlessly focused on “the why” of every story and seeks to enable a more intimate and immersive understanding of the issues that matter.
Read more »
Lilly sells Zepbound vials at 50% discount to meet weight loss drug demandEli Lilly & Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots.
Read more »
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supplyEli Lilly is offering 2.5-milligram and 5-milligram single-dose vials of Zepbound for $399 per month and $549 per month, respectively.
Read more »
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supplyEli Lilly is offering 2.5-milligram and 5-milligram single-dose vials of Zepbound for $399 per month and $549 per month, respectively.
Read more »